Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does KETOROLAC TROMETHAMINE Cause Hypotension? 81 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Hypotension have been filed in association with KETOROLAC TROMETHAMINE (ketorolac tromethamine). This represents 1.3% of all adverse event reports for KETOROLAC TROMETHAMINE.

81
Reports of Hypotension with KETOROLAC TROMETHAMINE
1.3%
of all KETOROLAC TROMETHAMINE reports
7
Deaths
47
Hospitalizations

How Dangerous Is Hypotension From KETOROLAC TROMETHAMINE?

Of the 81 reports, 7 (8.6%) resulted in death, 47 (58.0%) required hospitalization, and 14 (17.3%) were considered life-threatening.

Is Hypotension Listed in the Official Label?

Yes, Hypotension is listed as a known adverse reaction in the official FDA drug label for KETOROLAC TROMETHAMINE.

What Other Side Effects Does KETOROLAC TROMETHAMINE Cause?

Drug ineffective (1,172) Drug hypersensitivity (838) Treatment failure (776) Off label use (593) Nausea (501) Hyperhidrosis (353) Product use in unapproved indication (328) Nightmare (325) Sedation (319) Dyspnoea (244)

What Other Drugs Cause Hypotension?

SACUBITRIL\VALSARTAN (11,718) AMLODIPINE (6,504) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (4,694) FUROSEMIDE (4,468) TREPROSTINIL (4,412) METOPROLOL (3,213) RITUXIMAB (3,208) METFORMIN (3,116) LENALIDOMIDE (2,920) ACETAMINOPHEN (2,817)

Which KETOROLAC TROMETHAMINE Alternatives Have Lower Hypotension Risk?

KETOROLAC TROMETHAMINE vs KETOROLAC\KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE vs KETOTIFEN KETOROLAC TROMETHAMINE vs KLONOPIN KETOROLAC TROMETHAMINE vs L-ASPARAGINASE KETOROLAC TROMETHAMINE vs LABETALOL

Related Pages

KETOROLAC TROMETHAMINE Full Profile All Hypotension Reports All Drugs Causing Hypotension KETOROLAC TROMETHAMINE Demographics